9-95449257-G-A

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_000264.5(PTCH1):​c.3616C>T​(p.Arg1206Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000383 in 1,567,758 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1206H) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000037 ( 0 hom. )

Consequence

PTCH1
NM_000264.5 missense

Scores

4
11
4

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 4.70

Publications

1 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP6
Variant 9-95449257-G-A is Benign according to our data. Variant chr9-95449257-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 409182.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 7 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCH1NM_000264.5 linkc.3616C>T p.Arg1206Cys missense_variant Exon 22 of 24 ENST00000331920.11 NP_000255.2 Q13635-1
PTCH1NM_001083603.3 linkc.3613C>T p.Arg1205Cys missense_variant Exon 22 of 24 ENST00000437951.6 NP_001077072.1 Q13635-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCH1ENST00000331920.11 linkc.3616C>T p.Arg1206Cys missense_variant Exon 22 of 24 5 NM_000264.5 ENSP00000332353.6 Q13635-1
PTCH1ENST00000437951.6 linkc.3613C>T p.Arg1205Cys missense_variant Exon 22 of 24 5 NM_001083603.3 ENSP00000389744.2 Q13635-2

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152270
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000620
Gnomad FIN
AF:
0.0000941
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000405
AC:
7
AN:
172792
AF XY:
0.0000544
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000126
Gnomad NFE exome
AF:
0.0000422
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000374
AC:
53
AN:
1415488
Hom.:
0
Cov.:
31
AF XY:
0.0000286
AC XY:
20
AN XY:
699744
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32584
American (AMR)
AF:
0.00
AC:
0
AN:
36854
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25312
East Asian (EAS)
AF:
0.0000267
AC:
1
AN:
37418
South Asian (SAS)
AF:
0.000136
AC:
11
AN:
80906
European-Finnish (FIN)
AF:
0.0000601
AC:
3
AN:
49888
Middle Eastern (MID)
AF:
0.000524
AC:
3
AN:
5720
European-Non Finnish (NFE)
AF:
0.0000312
AC:
34
AN:
1088082
Other (OTH)
AF:
0.0000170
AC:
1
AN:
58724
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152270
Hom.:
0
Cov.:
33
AF XY:
0.0000807
AC XY:
6
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41478
American (AMR)
AF:
0.00
AC:
0
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5198
South Asian (SAS)
AF:
0.000620
AC:
3
AN:
4836
European-Finnish (FIN)
AF:
0.0000941
AC:
1
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68050
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000227
ExAC
AF:
0.0000254
AC:
3

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Gorlin syndrome Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hereditary cancer-predisposing syndrome Benign:1
Nov 15, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Pathogenic
0.20
D
BayesDel_noAF
Uncertain
0.040
CADD
Benign
22
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.74
D;.;.;.;.;.;.
Eigen
Benign
0.15
Eigen_PC
Benign
0.081
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.98
D;.;D;D;.;.;D
M_CAP
Pathogenic
0.55
D
MetaRNN
Uncertain
0.52
D;D;D;D;D;D;D
MetaSVM
Uncertain
0.57
D
MutationAssessor
Uncertain
2.2
M;.;.;.;.;.;.
PhyloP100
4.7
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-2.7
D;D;D;D;D;D;D
REVEL
Pathogenic
0.65
Sift
Uncertain
0.0010
D;D;D;D;D;D;D
Sift4G
Uncertain
0.0020
D;D;D;D;D;D;D
Polyphen
1.0
D;.;.;D;D;.;D
Vest4
0.71
MutPred
0.41
Gain of sheet (P = 0.0827);.;.;.;.;.;.;
MVP
0.56
MPC
0.36
ClinPred
0.64
D
GERP RS
3.3
Varity_R
0.46
gMVP
0.65
Mutation Taster
=69/31
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs772537644; hg19: chr9-98211539; API